HEALTHCARE · MEDICAL DEVICES

Insulet Corporation (PODD) Stock Price, Analysis & Trade Signals

$150.38+1.36 (+0.91%)

Insulet Corporation specializes in the creation, production, and distribution of advanced insulin management systems for individuals living with insulin-dependent diabetes. At the core of their offerings is the Omnipod System, an innovative solution featuring a unique, self-adhesive, and disposable Omnipod device. This tubeless unit can be directly applied to the body for a duration of up to three days, and it operates in conjunction with a wireless handheld personal diabetes manager. The company's products reach customers predominantly through independent distributors and pharmaceutical chann…

Market Cap
$15.99B
CEO
Ashley A. McEvoy
Employees
5,400
IPO Date
2007-05-15
Website
www.insulet.com

Tabs · Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics